Nita Lee to Antibodies, Monoclonal, Humanized
This is a "connection" page, showing publications Nita Lee has written about Antibodies, Monoclonal, Humanized.
Connection Strength
0.155
-
Pembrolizumab and lenvatinib versus carboplatin and paclitaxel as first-line therapy for advanced or recurrent endometrial cancer: A Markov analysis. Gynecol Oncol. 2021 08; 162(2):249-255.
Score: 0.127
-
Current recommendations and recent progress in endometrial cancer. CA Cancer J Clin. 2019 07; 69(4):258-279.
Score: 0.028